Daniel P. O'Day - Mar 1, 2022 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Chairman & CEO, Director
Signature
/s/ Amy Kim by Power of Attorney for Daniel O'Day
Stock symbol
GILD
Transactions as of
Mar 1, 2022
Transactions value $
-$1,400,744
Form type
4
Date filed
3/3/2022, 06:15 PM
Previous filing
Jan 28, 2022
Next filing
Mar 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +11.4K +5.53% 217K Mar 1, 2022 Direct F1
transaction GILD Common Stock Options Exercise +42.9K +19.81% 260K Mar 1, 2022 Direct F1
transaction GILD Common Stock Tax liability -$1.4M -23.2K -8.95% $60.26 236K Mar 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -11.4K -7.53% 139K Mar 1, 2022 Common Stock 11.4K Direct F1, F2
transaction GILD Restricted Stock Unit Options Exercise -42.9K -30.77% 96.6K Mar 1, 2022 Common Stock 42.9K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a four-year vesting schedule. 25% vest on each yearly anniversary of the date of grant until fully vested.
F3 The restricted stock units have a three year vesting schedule. 1/3 vest on each yearly anniversary of the date of grant until fully vested.